Entecavir demonstrates superior histologic and virologic efficacy over lamivudine in nucleoside-naive HBeAg(-) chronic hepatitis B: Results of phase III trial ETV-027.

被引：0
|
作者：
Shouval, D
Lai, CL
Cheinquer, H
Lok, A
DeHertogh, D
Wilber, R
Cross, A
Zink, R
Fernandes, L
机构：
[1] Hadassah Hebrew Univ Hosp, Jerusalem, Israel
[2] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
[3] Univ Fed Rio Grande Sul, Porto Alegre, RS, Brazil
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Univ Connecticut, Farmington, CT USA
[6] Bristol Myers Squibb Co, Pharmaceut Res Inst, Wallingford, CT 06492 USA
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：728A / 728A
页数：1
相关论文
共 50 条
  • [21] Entecavir is well-tolerated for treatment of chronic hepatitis B: Phase III safety analysis in nucleoside-naive and lamivudine-refractory patients
    Sollano, J
    Schiff, E
    Carrilho, F
    Raptopoulou-Gigi, M
    Cooney, E
    Hindes, R
    Cross, A
    DeHertogh, D
    ANTIVIRAL THERAPY, 2004, 9 (06) : H24 - H24
  • [22] The efficacy of entecavir is similar regardless of disease-related baseline subgroups in treatment of nucleoside-naive, HBeAg(+) and HBeAg(-) patients with chronic hepatitis B
    Lurie, Y
    Manns, MP
    Gish, RG
    Chang, TT
    Yurdaydin, C
    Lai, CL
    Shouval, D
    Brown, RS
    Apelian, D
    Fernandes, L
    Klesczewski, K
    Cross, A
    Wilber, R
    JOURNAL OF HEPATOLOGY, 2005, 42 : 184 - 184
  • [23] Efficacy and safety of entecavir in nucleoside-naive, chronic hepatitis B patients: Phase II clinical study in Japan
    Kobashi, Haruhiko
    Takaguchi, Kouichi
    Ikeda, Hiroshi
    Yokosuka, Osamu
    Moriyama, Mitsuhiko
    Imazeki, Fumio
    Kage, Masayoshi
    Seriu, Taku
    Omata, Masao
    Sakaguchi, Kousaku
    Shiratori, Yasushi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (02) : 255 - 261
  • [24] Efficacy of entecavir monotherapy in nucleoside-naive patients with chronic hepatitis B in a tertiary clinic setting
    Davison, S. A.
    Dobbins, T. A.
    Segaert, N.
    Koorey, D. J.
    Shackel, N. A.
    Bye, W. A.
    Selby, W. S.
    McCaughan, G. W.
    Strasser, S. I.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A282 - A282
  • [25] Long term efficacy, safety and resistance analyses of entecavir (ETV) treatment in Japanese nucleoside-naive patients with chronic hepatitis B (CHB)
    Mochida, S.
    Takaguchi, K.
    Yokosuka, O.
    Fujioka, S.
    Hayashi, N.
    Shindo, M.
    Chayama, K.
    Toyota, J.
    Ishikawa, H.
    Seriu, T.
    Omata, O.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S262 - S262
  • [26] Long-term efficacy, safety and resistance analyses of entecavir (ETV) treatment in Japanese nucleoside-naive patients with chronic hepatitis B (CHB)
    Omata, M.
    Takaguchi, K.
    Fujioka, S.
    Hayashi, N.
    Shindo, M.
    Chayama, K.
    Ishikawa, H.
    Seriu, T.
    Kobashi, H.
    Yokosuka, O.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A30 - A30
  • [27] Efficacy of entecavir treatment for up to 96 weeks in nucleoside-naive HBeAg-positive chronic hepatitis B patients with high viral load
    Yan, Li-Bo
    Chen, En-Qiang
    Bai, Lang
    Du, Ling-Yao
    Chen, Lan-Lan
    Liao, Juan
    He, Min
    Tang, Hong
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2015, 39 (03) : 366 - 372
  • [28] Continued virologic improvement through 96 weeks of Entecavir treatment in HBeAg(-) chronic hepatitis B patients (STUDY ETV-027)
    Poordad, Fred
    Dieterich, Douglas T.
    Min, Albert D.
    Shouval, Daniel
    Lai, Ching-Lung
    Cheinquer, Hugo
    Chang, Ting-Tsung
    Zink, Richard
    Zhu, Jin
    Brett-Smith, Helena
    GASTROENTEROLOGY, 2006, 130 (04) : A848 - A848
  • [29] Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naive Chinese patients with chronic hepatitis B: a randomized, multicenter study
    Yao, Guangbi
    Chen, ChengWei
    Lu, WeiLun
    Ren, Hong
    Tan, DeMing
    Wang, YuMing
    Xu, DaoZheng
    Liu, Jessica
    Xu, Dong
    Llamoso, Cyril
    HEPATOLOGY INTERNATIONAL, 2008, 2 (04) : 486 - 493
  • [30] Decline in Hepatitis B Surface Antigen Levels With Entecavir Treatment in HBeAg-Positive Nucleoside Naive Chronic Hepatitis B Patients- Results From Phase III Study ETV-022
    Gish, Robert
    Chang, Ting-Tsung
    Lai, Ching-Lung
    De Man, Robert A.
    Gadano, Adrien
    Yu, Song
    Llamoso, Cyril
    Tang, Hong
    GASTROENTEROLOGY, 2012, 142 (05) : S917 - S917
12345